280 related articles for article (PubMed ID: 16802346)
1. Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment.
Toh ML; Marotte H; Blond JL; Jhumka U; Eljaafari A; Mougin B; Miossec P
Arthritis Rheum; 2006 Jul; 54(7):2109-18. PubMed ID: 16802346
[TBL] [Abstract][Full Text] [Related]
2. Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression.
Toh ML; Gonzales G; Koenders MI; Tournadre A; Boyle D; Lubberts E; Zhou Y; Firestein GS; van den Berg WB; Miossec P
PLoS One; 2010 Oct; 5(10):e13416. PubMed ID: 20976214
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
[TBL] [Abstract][Full Text] [Related]
4. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade.
Heinhuis B; Koenders MI; van Riel PL; van de Loo FA; Dinarello CA; Netea MG; van den Berg WB; Joosten LA
Ann Rheum Dis; 2011 Apr; 70(4):660-7. PubMed ID: 21187297
[TBL] [Abstract][Full Text] [Related]
5. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
[TBL] [Abstract][Full Text] [Related]
7. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
Sekiguchi N; Kawauchi S; Furuya T; Inaba N; Matsuda K; Ando S; Ogasawara M; Aburatani H; Kameda H; Amano K; Abe T; Ito S; Takeuchi T
Rheumatology (Oxford); 2008 Jun; 47(6):780-8. PubMed ID: 18388148
[TBL] [Abstract][Full Text] [Related]
8. Synergism between tumor necrosis factor alpha and interleukin-17 to induce IL-23 p19 expression in fibroblast-like synoviocytes.
Goldberg M; Nadiv O; Luknar-Gabor N; Agar G; Beer Y; Katz Y
Mol Immunol; 2009 May; 46(8-9):1854-9. PubMed ID: 19201028
[TBL] [Abstract][Full Text] [Related]
9. Application of a new immunohistology scoring system (IH score): analysis of TNF-α in synovium related to disease activity score in infliximab-treated patients with rheumatoid arthritis.
Kanbe K; Hara R; Chiba J; Inoue Y; Taguchi M; Tanaka Y
Mod Rheumatol; 2014 Nov; 24(6):910-4. PubMed ID: 24670132
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-34 produced by human fibroblast-like synovial cells in rheumatoid arthritis supports osteoclastogenesis.
Hwang SJ; Choi B; Kang SS; Chang JH; Kim YG; Chung YH; Sohn DH; So MW; Lee CK; Robinson WH; Chang EJ
Arthritis Res Ther; 2012 Jan; 14(1):R14. PubMed ID: 22264405
[TBL] [Abstract][Full Text] [Related]
11. GDF-5 is suppressed by IL-1beta and enhances TGF-beta3-mediated chondrogenic differentiation in human rheumatoid fibroblast-like synoviocytes.
Liu FL; Lin LH; Sytwu HK; Chang DM
Exp Mol Pathol; 2010 Feb; 88(1):163-70. PubMed ID: 19818765
[TBL] [Abstract][Full Text] [Related]
12. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor alpha in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor kappaB-mediated induction of the Ets transcription factor ESE-1.
Grall F; Gu X; Tan L; Cho JY; Inan MS; Pettit AR; Thamrongsak U; Choy BK; Manning C; Akbarali Y; Zerbini L; Rudders S; Goldring SR; Gravallese EM; Oettgen P; Goldring MB; Libermann TA
Arthritis Rheum; 2003 May; 48(5):1249-60. PubMed ID: 12746898
[TBL] [Abstract][Full Text] [Related]
13. Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis.
Gui H; Liu X; Wang ZW; He DY; Su DF; Dai SM
Rheumatology (Oxford); 2014 May; 53(5):802-9. PubMed ID: 24440992
[TBL] [Abstract][Full Text] [Related]
14. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
[TBL] [Abstract][Full Text] [Related]
15. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
17. Six-transmembrane epithelial antigen of prostate4 (STEAP4) is a tumor necrosis factor alpha-induced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis.
Tanaka Y; Matsumoto I; Iwanami K; Inoue A; Minami R; Umeda N; Kanamori A; Ochiai N; Miyazawa K; Sugihara M; Hayashi T; Goto D; Ito S; Sumida T
Mod Rheumatol; 2012 Feb; 22(1):128-36. PubMed ID: 21633911
[TBL] [Abstract][Full Text] [Related]
18. Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.
Marotte H; Arnaud B; Diasparra J; Zrioual S; Miossec P
Arthritis Rheum; 2008 May; 58(5):1258-63. PubMed ID: 18438841
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha induces vascular endothelial growth factor-C expression in rheumatoid synoviocytes.
Cha HS; Bae EK; Koh JH; Chai JY; Jeon CH; Ahn KS; Kim J; Koh EM
J Rheumatol; 2007 Jan; 34(1):16-9. PubMed ID: 17216674
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.
Aradi B; Kato M; Filkova M; Karouzakis E; Klein K; Scharl M; Kolling C; Michel BA; Gay RE; Buzas EI; Gay S; Jüngel A
Arthritis Rheumatol; 2015 Oct; 67(10):2624-33. PubMed ID: 26139109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
